|
|
|
|
Office Locations:
|
345 Park Avenue
New York, NY 10154
Phone: 212-583-5000
Fax: 212-583-5749
| |
|
|
|
|
|
Business Services
Consumer Products & Services
Information Technology
Manufacturing & Industrial
Real Estate & Construction
Retail & Restaurant
Sports & Entertainment
|
|
|
Founded in 1985, Blackstone is a leading global alternative asset manager and provider of financial advisory services (listed on the New York Stock Exchange) with total assets under management of approximately $975 billion. Blackstone's private equity team has invested in 115 portfolio companies in a variety of industries and geographies. The group has $127 billion total assets under management with $36 billion in available capital to invest. The firm's alternative asset management businesses include the management of Corporate Private Equity funds; Real Estate opportunity funds; and Marketable Alternative Asset Management funds, including: Funds of Hedge fund, Mezzanine funds, Senior Debt Vehicles, Proprietary Hedge funds, and Closed-End Mutual funds. Blackstone has additional offices in Boston, Atlanta, Dallas, Chicago, Los Angeles, San Francisco, Paris, London, Hong Kong, Mumbai, and Tokyo.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage (includes "pre-seed," or concept stage) | No Revenue |
| Early Stage | Minimal Revenue |
Growth Stage (also called Mid-stage) | $2M-$7M |
Expansion Stage (also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
|
| Name | |
| |
Title | |
|
| Brian Gavin | |
| |
Senior Managing Director | |
| David I. Foley | |
| |
Senior Managing Director | |
| Hilary Hung | |
| |
Managing Director | |
| Martin Brand | |
| |
Head of North America Private Equity | |
| Nicholas Galakatos | |
| |
Global Head of Life Sciences | |
|
|
|
Date
|
Name
|
State
|
Amount
|
Stage
|
07/13/2026
|
Norm Ai
|
NY
|
$120,000,000
|
Series C
|
07/01/2026
|
Ollin Biosciences
|
TX
|
$330,000,000
|
Series B
|
06/10/2026
|
Cyera
|
CA
|
$600,000,000
|
|
05/18/2026
|
VoltaGrid
|
TX
|
$1,000,000,000
|
|
04/25/2026
|
TextQL
|
CA
|
$17,000,000
|
|
03/30/2026
|
Shield AI
|
CA
|
$2,000,000,000
|
Series G
|
02/16/2026
|
Anthropic
|
CA
|
$30,000,000,000
|
Series G
|
01/08/2026
|
Cyera
|
CA
|
$400,000,000
|
Series F
|
12/16/2025
|
Databricks
|
CA
|
$4,000,000,000
|
Series L
|
08/06/2025
|
MannKind
|
CT
|
$500,000,000
|
Strategic
|
|
|
|
|
|
|
|